{BLR 431} Patent Infringement - Monoclonal Antibodies, Inc. - Hybritech, Inc.
1985; Mary Ann Liebert, Inc.; Volume: 4; Issue: 10 Linguagem: Inglês
10.1089/blr.1985.4.302
ISSN1557-8704
Tópico(s)Copyright and Intellectual Property
ResumoBiotechnology Law ReportVol. 4, No. 10 {BLR 431} Patent Infringement - Monoclonal Antibodies, Inc. - Hybritech, Inc.MONOCLONAL ANTIBODIES, INC. WINS PATENT INFRINGEMENT LAWSUIT BROUGHT BY HYBRITECH, INC.Published Online:23 Mar 2009https://doi.org/10.1089/blr.1985.4.302AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byOngoing Royalties for Patent InfringementSSRN Electronic JournalLinking Patent Reform and Civil Litigation ReformSSRN Electronic JournalAntitrust and the Patent System: A ReexaminationSSRN Electronic JournalUnpatentability by Design: The Overlooked Use of Inter Partes and Post-Grant Review to Challenge Design PatentsSSRN Electronic JournalA Natural Experiment: Asset Manager LiabilitySSRN Electronic JournalThird Supplemental Declaration of J. Gregory Sidak Concerning the Competitive Consequences of the Proposed Merger of Sirius Satellite Radio, Inc. and XM Satellite Radio, Inc.SSRN Electronic JournalDictionary-Based Data Compression Volume 4Issue 10Oct 1985 To cite this article:{BLR 431} Patent Infringement - Monoclonal Antibodies, Inc. - Hybritech, Inc..Biotechnology Law Report.Oct 1985.302-330.http://doi.org/10.1089/blr.1985.4.302Published in Volume: 4 Issue 10: March 23, 2009PDF download
Referência(s)